Skip to main content


Blog Post Directory

Moving forward: 6 points to expect with your APS preclinical research program
If you’re coming to APS with one of your first new medical devices, you may be uncertain how your preclinical
Read more.
New APS canine model enables better arthritis research
When APS scientists approached their company executives six years ago about initiating a new procedure for the study of arthritis,
Read more.
Your biocompatibility test failed. Now what?
The biocompatibility testing phase is an exciting time for producers of medical devices. It’s the first time you really get
Read more.
APS COVID-19 Response
Working with APS during these Unprecedented Times Updated 3/26/20 As we are all aware, the spread of Coronavirus (COVID-19) has prompted
Read more.
APS’ human blood loop assay points to the future of hemocompatibility testing
APS has found a way to improve hemocompatibility testing for researchers seeking final FDA approval on blood-contacting medical devices —
Read more.
APS’ incoming CSO brings years of experience in pharmaceutical and medical device research
As Dr. Jim Pomonis of APS gets ready to step into the next stage of his career, he can look
Read more.
World-class facilities empower preclinical success
To achieve truly revolutionary breakthroughs in the field of medical science, you need the right tools. At American Preclinical Services,
Read more.
FDA Finalizes 510(k) Guidances on When to Submit a New 510(k)
On October 25, 2017, the FDA released two final guidance documents: “Deciding When to Submit a 510(k) for a Change
Read more.
FDA’s plan to engage the public in the agency’s new effort to strengthen and modernize FDA’s regulatory framework
On 07 September, 2017, FDA announced its plan to engage the public in the agency’s new effort to strengthen and
Read more.
Strengthening EU-US cooperation in medicine inspections
New commitment allows FDA to share full inspection reports with European Commission and EMA The European Commission (EC), the United
Read more.